Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Otto Metzger, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gaglia G, Kabraji S, Rammos D, Dai Y, Verma A, Wang S, Mills CE, Chung M, Bergholz JS, Coy S, Lin JR, Jeselsohn R, Metzger O, Winer EP, Dillon DA, Zhao JJ, Sorger PK, Santagata S. Temporal and spatial topography of cell proliferation in cancer. Nat Cell Biol. 2022 Mar; 24(3):316-326. PMID: 35292783.
    Citations: 1     Fields:    
  2. Geyer CE, Sikov WM, Huober J, Rugo HS, Wolmark N, O'Shaughnessy J, Maag D, Untch M, Golshan M, Lorenzo JP, Metzger O, Dunbar M, Symmans WF, Rastogi P, Sohn JH, Young R, Wright GS, Harkness C, McIntyre K, Yardley D, Loibl S. Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial. Ann Oncol. 2022 Apr; 33(4):384-394. PMID: 35093516.
    Citations:    Fields:    
  3. Nunes R, Sella T, Treuner K, Atkinson JM, Wong J, Zhang Y, Exman P, Dabbs D, Richardson AL, Schnabel CA, Sgroi DC, Oesterreich S, Cimino-Mathews A, Metzger O. Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma. Clin Cancer Res. 2021 10 15; 27(20):5688-5696. PMID: 34376532.
    Citations: 1     Fields:    
  4. Pate L, Desmedt C, Metzger O, Burgess Hutcheson L, Turner C, Freeney S, Oesterreich S. How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research. Cancers (Basel). 2021 Jun 22; 13(13). PMID: 34206261.
    Citations: 1     
  5. Filho OM, Viale G, Stein S, Trippa L, Yardley DA, Mayer IA, Abramson VG, Arteaga CL, Spring LM, Waks AG, Wrabel E, DeMeo MK, Bardia A, Dell'Orto P, Russo L, King TA, Polyak K, Michor F, Winer EP, Krop IE. Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab. Cancer Discov. 2021 10; 11(10):2474-2487. PMID: 33941592.
    Citations: 5     Fields:    Translation:CTClinical Trials
  6. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020; 6:35. PMID: 32821803.
    Citations: 5     
  7. Kantor O, Wong S, Weiss A, Metzger O, Mittendorf EA, King TA. Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer. NPJ Breast Cancer. 2020 Aug 13; 6(1):35. PMID: 33579920.
    Citations:    
  8. Metzger Filho O, Leone JP, Li T, Tan-Wasielewski Z, Trippa L, Barry WT, Younger J, Lawler E, Walker L, Freedman RA, Tolaney SM, Krop I, Winer EP, Lin NU. Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases. Ann Oncol. 2020 09; 31(9):1231-1239. PMID: 32461105.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  9. Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M. Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents. Oncologist. 2020 06; 25(6):e900-e908. PMID: 32176406.
    Citations: 3     Fields:    Translation:Humans
  10. Weiss A, Wong S, Golshan M, Freedman RA, Metzger O, Bellon J, Mittendorf EA, King TA. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach. Ann Surg Oncol. 2019 Dec; 26(13):4326-4336. PMID: 31562601.
    Citations: 6     Fields:    Translation:Humans
  11. Metzger-Filho O, Ferreira AR, Jeselsohn R, Barry WT, Dillon DA, Brock JE, Vaz-Luis I, Hughes ME, Winer EP, Lin NU. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade. Oncologist. 2019 07; 24(7):e441-e449. PMID: 30518616.
    Citations: 9     Fields:    Translation:Humans
  12. Desmedt C, Zoppoli G, Gundem G, Pruneri G, Larsimont D, Fornili M, Fumagalli D, Brown D, Rothé F, Vincent D, Kheddoumi N, Rouas G, Majjaj S, Brohée S, Van Loo P, Maisonneuve P, Salgado R, Van Brussel T, Lambrechts D, Bose R, Metzger O, Galant C, Bertucci F, Piccart-Gebhart M, Viale G, Biganzoli E, Campbell PJ, Sotiriou C. Genomic Characterization of Primary Invasive Lobular Breast Cancer. J Clin Oncol. 2016 06 01; 34(16):1872-81. PMID: 26926684.
    Citations: 95     Fields:    Translation:Humans
  13. Metzger-Filho O, de Azambuja E, Procter M, Krieguer M, Smith I, Baselga J, Cameron D, Untch M, Jackisch C, Bell R, Gianni L, Goldhirsch A, Piccart M, Gelber RD. Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience. Breast Cancer Res Treat. 2016 Jan; 155(1):127-32. PMID: 26708471.
    Citations: 2     Fields:    Translation:Humans
  14. Metzger Filho O, Giobbie-Hurder A, Mallon E, Gusterson B, Viale G, Winer EP, Thürlimann B, Gelber RD, Colleoni M, Ejlertsen B, Debled M, Price KN, Regan MM, Coates AS, Goldhirsch A. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial. J Clin Oncol. 2015 Sep 01; 33(25):2772-9. PMID: 26215945.
    Citations: 44     Fields:    Translation:Humans
  15. Metzger-Filho O, de Azambuja E, Bradbury I, Saini KS, Bines J, Simon SD, Dooren VV, Aktan G, Pritchard KI, Wolff AC, Smith I, Jackisch C, Lang I, Untch M, Boyle F, Xu B, Baselga J, Perez EA, Piccart-Gebhart M. Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience. Oncologist. 2013; 18(2):134-40. PMID: 23359433.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  16. Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart M, Sotiriou C, Fuks F. DNA methylation profiling reveals a predominant immune component in breast cancers. EMBO Mol Med. 2011 Dec; 3(12):726-41. PMID: 21910250.
    Citations: 107     Fields:    Translation:HumansCells
  17. Fumagalli D, Metzger O, Veys I, Catteau A, Michiels S, Sandy H, Salgado R, Singhal SK, Saini KV, Galant C, Galland N, Bertucci F, Peyro Saint Paul HP, Piccart-Gebhart MJ, Sotiriou C, Larsimont D. Use of genomic grade index to improve tumor grading of invasive lobular breast carcinoma. J Clin Oncol. 2011 May 20; 29(15_suppl):535. PMID: 28021482.
    Citations:    
  18. Metzger O, Catteau A, Michiels S, Buyse ME, Saini KV, Fasolo V, Canon J, Delrée P, Coibion M, Jossa V, Kains J, Larsimont D, Richard V, Faverly D, Cornez N, Vuylsteke P, Vanderschueren B, Peyro Saint Paul HP, Piccart-Gebhart MJ, Sotiriou C. Genomic grade: Feasibility in routine practice and influence on treatment decision in early breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):606. PMID: 28021187.
    Citations:    
  19. Klotz G, Metzger O, North P. [A case of cortical blindness in the course of an otological intervention]. Rev Otoneuroophtalmol. 1973 Oct-Dec; 45(5):427-8. PMID: 4793207.
    Citations:    Fields:    Translation:Humans
  20. Rohmer F, Metzger O, North P. [Nystagmus retractorius or clonus retractorius. Apropos of 15 cases observed in the Clinique Neurologique de Strasbourg since 1945]. Rev Otoneuroophtalmol. 1972 Jan-Feb; 44(1):81-7. PMID: 4653520.
    Citations:    Fields:    Translation:Humans
  21. Metzger O, Collard M, Conraux C, Neymann G. [Total unilateral regressive deafness associated with the development of multiple sclerosis]. Rev Otoneuroophtalmol. 1967 Apr; 39(3):128-9. PMID: 5304768.
    Citations:    Fields:    Translation:Humans
  22. Metzger O, Mengus M, Jesel M, Buchheit F. [Diagnostic pitfalls apropos of a case of acoustic neurinoma: pre- and postoperative considerations]. Rev Otoneuroophtalmol. 1966 Mar-Apr; 38(2):102-5. PMID: 5931083.
    Citations: 1     Fields:    Translation:Humans
  23. Thiébaut F, Matavulj N, Metzger O. [Cortical blindness with favorable prognosis occurring after the 6th delivery]. Bull Mem Soc Fr Ophtalmol. 1966; 79:266-73. PMID: 6015494.
    Citations:    Fields:    
  24. METZGER O. [Arteriosclerosis of the nervous system and neurosurgery. Diagnostic difficulties apropos of some recent cases]. Strasb Med. 1963 Feb; 14:135-8. PMID: 13935219.
    Citations:    Translation:Humans
  25. THIEBAUT F, METZGER O, JESEL M, VROUSOS C. [4 cases of venous encephalopathy]. Rev Otoneuroophtalmol. 1963 Jan-Feb; 35:10-3. PMID: 13980927.
    Citations:    Fields:    Translation:Humans
  26. METZGER O, PHILIPPIDES D. [Actinomycotic cerebral abscess (nocardiasis). Operation and recovery]. Rev Otoneuroophtalmol. 1962 Mar-Apr; 34:76-9. PMID: 13935218.
    Citations:    Fields:    Translation:Humans
  27. METZGER O, MENGUS M, JESEL M. [Basilar impression: minimal clinical symptomatology]. Rev Otoneuroophtalmol. 1960 Oct; 32:439-42. PMID: 13769912.
    Citations:    Fields:    
  28. ROHMER F, METZGER O, MENGUS M, WACKENHEIM A. [Complex syndrome of the posterior fossa with malformations of the cranio-spinal joint. (O.N.O. and radiological study)]. Rev Otoneuroophtalmol. 1960; 32:211-7. PMID: 14438435.
    Citations:    Fields:    Translation:Humans
  29. METZGER O, MENGUS M, JESEL M. [Otitis and cerebral disorders. Complications and coincidences. Apropos of 4 cases]. Confin Neurol. 1960; 20:382-7. PMID: 13769913.
    Citations:    Fields:    Translation:Humans
  30. THIEBAUT F, METZGER O. [2 cases of upper forms of the Guillain-Barre-Strohl syndrome]. Confin Neurol. 1960; 20:390-3. PMID: 13776283.
    Citations:    Fields:    Translation:Humans
  31. METZGER O. [Thoughts on the management in case of a light & recent cerebral shock]. Arch Mal Prof. 1958 Jul-Aug; 19(4):414-6. PMID: 13584082.
    Citations:    Fields:    Translation:Humans
  32. METZGER O. [Several cases of combined sclerosis of the spinal cord]. Strasb Med. 1957 Nov; 8(10):836-40. PMID: 13529481.
    Citations:    Translation:Humans
  33. THIEBAUT F, METZGER O, EBTINGER J. [Retinal hemorrhage, 1st symptom of a parasagittal meningioma]. Rev Otoneuroophtalmol. 1957; 29(7):426-7. PMID: 13528399.
    Citations:    Fields:    Translation:Humans
  34. METZGER O. [Wallenberg syndrome]. Strasb Med. 1956 Dec; 7(11):853-5. PMID: 13422051.
    Citations:    
  35. THIEBAUT F, PHILIPPIDES D, METZGER O. [Two cases of dorsal epiduritis cured by laminectomy]. Neurochirurgie. 1956 Apr-Jun; 2(2):223-7. PMID: 13348456.
    Citations:    Fields:    Translation:Humans
  36. GREINER GF, METZGER O. [Indication and technic of cervical sympathetic infiltration in facial paralysies and their sequelae]. Rev Otoneuroophtalmol. 1956; 28(2):84-7. PMID: 13390379.
    Citations:    Fields:    Translation:Humans
  37. THIEBAUT F, METZGER O, MATAVULJ N. [Retraction nystagmus in a patient afflicted with an intrapedoncular tumor, treated by Torkildsen's derivation]. Rev Otoneuroophtalmol. 1956; 28(7):415-6. PMID: 13442334.
    Citations:    Fields:    Translation:Humans
  38. Dany A, Holderbach L, Kempf Y, Metzger O, Thomas C. [Unilateral ponto-cerebellar angle syndrome in a case of Hodgkin's disease]. Rev Otoneuroophtalmol. 1956; 28(2):112-4. PMID: 13390387.
    Citations:    Fields:    
  39. METZGER O, THIEBAUT F. Study of opto-kinetic and vestibular nystagmus in a case of vertical descending nystagmus. Rev Otoneuroophtalmol. 1956; 28(1):22-3. PMID: 13390367.
    Citations:    Fields:    
  40. ISRAEL L, METZGER O, THIEBAUT F. [Ocular signs of botulism]. Rev Otoneuroophtalmol. 1955; 27(4):238-40. PMID: 13371124.
    Citations:    Fields:    Translation:Humans
  41. THIEBAUT F, METZGER O, ISRAEL L, MENGUS M. [Neurinoma of the acoustic nerve without deafness]. Rev Otoneuroophtalmol. 1954; 26(4):213-6. PMID: 14372685.
    Citations:    Fields:    
  42. THIEBAUT F, METZGER O, PHILIPPIDES D, WACKENHEIM A. [Cerebellar tumor revealed by pregnancy in a woman with Weill-Reys alias Adie syndrome]. Rev Otoneuroophtalmol. 1954; 26(4):216-8. PMID: 14372686.
    Citations:    Fields:    Translation:Humans
  43. THIEBAUT F, METZGER O, PHILIPPIDES D, MENGUS M. [Facial neuralgia as a symptom of lesion of the gasserian ganglion; surgery and cure]. Rev Otoneuroophtalmol. 1953 Jul; 25(5):293-4. PMID: 13112918.
    Citations:    Fields:    
  44. METZGER O. [Brain tumors without papillary stasis]. Strasb Med. 1953 Jul; 4(7):425-8. PMID: 13102130.
    Citations:    Translation:Humans
  45. METZGER O, PHILIPPIDES D. [Posttraumatic headache located in the left temporal region for 12 years; appearance of a malignant cerebral tumor in the same region]. Rev Otoneuroophtalmol. 1953; 25(7):444-5. PMID: 13167960.
    Citations:    Fields:    Translation:Humans
  46. METZGER O. [Value of research of position nystagmus in vestibular symptomatology]. Rev Otoneuroophtalmol. 1953; 25(7):406-12. PMID: 13167949.
    Citations:    Fields:    
  47. METZGER O. [Sympathetic ophthalmia, oto-neuro-ophthalmologic syndrome]. Rev Otoneuroophtalmol. 1952 Aug-Sep; 24(6):347-50. PMID: 13027982.
    Citations:    Fields:    Translation:Humans
  48. METZGER O. [Epilepsies from the neurological point of view]. Strasb Med. 1952 Aug; 3(8):623-8. PMID: 13028860.
    Citations:    Translation:Humans
  49. METZGER O, GREINER G, DORNER M. Polynucleate meningitis of the base of the skull and the upper part of the spine, secondary to nasopharyngeal inflammation. Confin Neurol. 1949; 9(5-6):430-2. PMID: 18143888.
    Citations:    Fields:    Translation:Humans
  50. METZGER O, PHILIPPIDES D. Study of a Parinaud syndrome during the course of a chronic subdural hematoma. Rev Otoneuroophtalmol. 1948 Aug-Sep; 20(6):377. PMID: 18102520.
    Citations:    Fields:    Translation:Humans
  51. ODY F, METZGER O. A rare, but sure, sign of the upper mesencephalic lesion, nystagmus retractorius. Confin Neurol. 1948; 8(4):222-4. PMID: 18878004.
    Citations:    Fields:    Translation:Humans
  52. METZGER O. Abscess of the cerebellum of otogenic origin; Surgical intervention; Aspiration; Healing for three years and six months. Rev Otoneuroophtalmol. 1946 Mar; 18(8):165-8. PMID: 20291915.
    Citations:    Fields:    
  53. ODY F, FIETTA P, METZGER O. Is exophthalmos a localizing symptom of a brain tumor? Confin Neurol. 1944-1945; 6(5):249-55. PMID: 21013995.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Metzger's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (165)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.